Respiratory Syncytial Virus (RSV) Therapeutics Market Size, Share and Forecast 2031
The Respiratory Syncytial Virus (RSV) Therapeutics Market in 2023 is US$ 1.35 billion, and is expected to reach US$ 11.82 billion by 2031 at a CAGR of 31.10%.
The Respiratory Syncytial Virus (RSV) Therapeutics Market in 2023 is US$ 1.35 billion, and is expected to reach US$ 11.82 billion by 2031 at a CAGR of 31.10%.